Results 221 to 230 of about 2,608,939 (298)

Class visualizations and activation atlases for computational pathology. [PDF]

open access: yesCell Rep Med
Gustav M   +8 more
europepmc   +1 more source

Reduction of Intestinal Redox Potential by Coated Ferulic Acid Accelerates Microbial Restoration and Restricts Enterotoxigenic Escherichia coli Colonization in Weaned Piglets

open access: yesAnimal Research and One Health, EarlyView.
Schematic illustration showing the distinct microbe–host crosstalk patterns shaped by intestinal redox potential. The orange‐blue gradient indicated the redox potential transition from a low to a high potential microenvironment. Under low redox potential, Lactobacillus, Ligilactobacillus, Lachnospira, Roseburia, and Lachnoclostridium promoted ...
Ni Feng   +4 more
wiley   +1 more source

Molecular mechanisms of colorectal cancer: from carcinogenesis and molecular classification to targeted therapy. [PDF]

open access: yesMol Med
Aldeyarbi S   +5 more
europepmc   +1 more source

Development of A Classification Framework for Colon Cancer

open access: yesInternational Journal of e-Healthcare Information Systems
V. I. Ainoko   +4 more
openaire   +1 more source

Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Atypical colitis (presenting reverse gradient colitis, backwash ileitis or rectal sparing) is associated with primary sclerosing cholangitis–ulcerative colitis (PSC). Oral vancomycin has been used to manage paediatric atypical colitis with/without confirmed PSC. Different preparations had shown different efficacy.
Laura Räisänen   +4 more
wiley   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang   +6 more
wiley   +1 more source

Clinical characteristics and phenotypes of inflammatory bowel disease in Northern Central America: initial results from the Northern Central America Inflammatory Bowel Disease Registry. [PDF]

open access: yesCrohns Colitis 360
Montalvan-Sanchez EE   +16 more
europepmc   +1 more source

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad   +4 more
wiley   +1 more source

Extracellular Vesicles‐Based Biological Macromolecule Delivery Systems: Biogenesis, Characterization, and Emerging Clinical Applications

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are nanoscale membrane‐bound structures that play a pivotal role in intercellular communication by transporting bioactive molecules, including proteins, lipids, nucleic acids, and organelles, between cells. Originating from the endosomal pathway, EVs reflect the physiological and pathological status of their parent
Emine İncilay Torunoğlu   +3 more
wiley   +1 more source

Mayo Clinic classification of presacral tumors: evolution of classifications and systematic review of pathologies. [PDF]

open access: yesBJS Open
Perry WRG   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy